BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12369341)

  • 1. Current drug treatments for lipid management.
    Stone NJ
    Manag Care; 2002 Sep; 11(9 Suppl):4-9. PubMed ID: 12369341
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs for lipids.
    Treat Guidel Med Lett; 2005 Mar; 3(31):15-22. PubMed ID: 15726011
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of lipid-lowering drug therapy on small-dense low-density lipoprotein.
    Backes JM; Gibson CA
    Ann Pharmacother; 2005 Mar; 39(3):523-6. PubMed ID: 15671087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapy.
    Duvall WL; Blazing MA; Saxena S; Guyton JR
    J Cardiovasc Risk; 2002 Dec; 9(6):339-47. PubMed ID: 12478203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I; Krone W
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifying plasma low-density lipoprotein and high-density lipoprotein cholesterol: what combinations are available in the future?
    Kastelein JJ
    Am J Cardiol; 2005 Nov; 96(9A):20K-27K; discussion 34K-35K. PubMed ID: 16291010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy and clinical trials: HDL-cholesterol and niacin therapy--past, present, and future.
    Virani SS; Ballantyne CM
    Curr Opin Lipidol; 2010 Apr; 21(2):165-6. PubMed ID: 20616632
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors].
    Broncel M; Balcerak M; Chojnowska-Jezierska J
    Pol Merkur Lekarski; 2007 Jan; 22(127):62-5. PubMed ID: 17477094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of dyslipidemia in clinical practice].
    Paragh G; Harangi M
    Orv Hetil; 2006 Mar; 147(9):389-94. PubMed ID: 16619956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R; Goldberg AC
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of lipid-regulating drugs.
    Med Lett Drugs Ther; 2001 May; 43(1105):43-8. PubMed ID: 11378632
    [No Abstract]   [Full Text] [Related]  

  • 12. Choosing drug therapy for patients with hyperlipidemia.
    Safeer RS; Lacivita CL
    Am Fam Physician; 2000 Jun; 61(11):3371-82. PubMed ID: 10865931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of dyslipidemia--what's left in the pipeline?
    Rau O; Zettl H; Popescu L; Steinhilber D; Schubert-Zsilavecz M
    ChemMedChem; 2008 Feb; 3(2):206-21. PubMed ID: 17963209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events.
    Balbisi EA
    Med Sci Monit; 2006 Feb; 12(2):RA34-9. PubMed ID: 16449961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipid therapy in risk patients. Do we concentrate too much on LDL cholesterol?].
    März W
    MMW Fortschr Med; 2005 Apr; 147(14):14. PubMed ID: 15887675
    [No Abstract]   [Full Text] [Related]  

  • 17. Rationale for aggressive lipid lowering: evidence from clinical trials.
    Farmer JA
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):305-9. PubMed ID: 15151477
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dyslipidemia management in patients with impaired glucose tolerance].
    Asano M; Yamada N
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():538-42. PubMed ID: 15779437
    [No Abstract]   [Full Text] [Related]  

  • 19. New options in lipid management--can we extend the benefits of current therapy? Introduction.
    Gotto AM; Paoletti R
    Am Heart J; 2002 Dec; 144(6 Suppl):S19-20. PubMed ID: 12486411
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid management in the geriatric patient.
    Nair AP; Darrow B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.